Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice
about
Interactions of Opioids and HIV Infection in the Pathogenesis of Chronic PainInteraction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System DiseaseRole of Oxidative Stress in HIV-1-Associated Neurocognitive Disorder and Protection by Gene Delivery of Antioxidant EnzymesHIV-1 Tat exacerbates lipopolysaccharide-induced cytokine release via TLR4 signaling in the enteric nervous system.Morphine induces expression of platelet-derived growth factor in human brain microvascular endothelial cells: implication for vascular permeabilityMorphine enhances HIV-1SF162-mediated neuron death and delays recovery of injured neuritesMorphine induces the release of CCL5 from astrocytes: potential neuroprotective mechanism against the HIV protein gp120Exposure to HIV-1 Tat in brain impairs sensorimotor gating and activates microglia in limbic and extralimbic brain regions of male mice.HIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation.Quantitation of parvalbumin+ neurons and human immunodeficiency virus type 1 (HIV-1) regulatory gene expression in the HIV-1 transgenic rat: effects of vitamin A deficiency and morphineFulminant encephalopathy with basal ganglia hyperintensities in HIV-infected drug users.Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neuronsInteractive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na⁺ influx, mitochondrial instability, and Ca²⁺ overload.Chronic central nervous system expression of HIV-1 Tat leads to accelerated rarefaction of neocortical capillaries and loss of red blood cell velocity heterogeneity.beta-Chemokine production by neural and glial progenitor cells is enhanced by HIV-1 Tat: effects on microglial migration.Effects of HIV-1 Tat on enteric neuropathogenesis.Transient hypercapnia reveals an underlying cerebrovascular pathology in a murine model for HIV-1 associated neuroinflammation: role of NO-cGMP signaling and normalization by inhibition of cyclic nucleotide phosphodiesterase-5Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.Effects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behaviorRelB/p50 complexes regulate cytokine-induced YKL-40 expressionSensitization of enteric neurons to morphine by HIV-1 Tat protein.Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia.Chronic SIV and morphine treatment increases heat shock protein 5 expression at the synapse.Editorial neuroAIDS review.Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and deathSubstance abuse increases the risk of neuropathy in an HIV-infected cohortMorphine affects HIV-induced inflammatory response without influencing viral replication in human monocyte-derived macrophagesOligodendrocytes Are Targets of HIV-1 Tat: NMDA and AMPA Receptor-Mediated Effects on Survival and Development.Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat.A placebo-controlled trial of dextromethorphan as an adjunct in opioid-dependent patients undergoing methadone maintenance treatmentMorphine efficacy is altered in conditional HIV-1 Tat transgenic mice.Phenotype-dependent alteration of pathways and networks reveals a pure synergistic mechanism for compounds treating mouse cerebral ischemia.Opiate drug use and the pathophysiology of neuroAIDS.Low-dose memantine attenuated methadone dose in opioid-dependent patients: a 12-week double-blind randomized controlled trial.Chronic HIV-1 Tat and HIV reduce Rbfox3/NeuN: evidence for sex-related effectsHIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase.Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic Mice.Gene delivery of antioxidant enzymes inhibits human immunodeficiency virus type 1 gp120-induced expression of caspases.Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 Tat transgenic mice.
P2860
Q26768068-FF778023-20DC-4214-8979-576CD6AD7226Q26770397-D7DF4E95-C85F-4608-B44A-D0BAC13DBA75Q26829535-8C3B8AE5-EB9C-49AB-84A6-DAF87C652055Q27318687-BEFAC3B0-F104-4563-B9D3-AAE53C42EA61Q28478866-0E5C9695-7C32-40B9-858E-5144FB1FDD56Q28539889-B0379945-A57F-4D54-B488-CB76CA4B57C3Q28570764-714FCB7A-06F5-4B42-A620-EC4181860729Q30374429-DBA3165D-A5C1-4D88-B99C-4EEAC507932AQ33647438-D7640A5A-7F68-47EE-811E-907FF46E525BQ33653493-F072818D-0569-413A-8276-E8CC2DCB8600Q33831555-924BB12B-8FAE-4E05-A2B1-80576EF884A5Q34086976-27086F13-4C4D-40A7-B3D8-6B137C9DE0B6Q34197724-D5E6F857-0200-4953-A3FF-805BFFF9C59CQ34324750-A31DC4C8-FD15-4BEA-90E6-260D8CC68CA3Q34356438-95BAAAAF-4D54-4BCB-AA30-EF6AA91A339BQ34383417-DE917DC1-1AE2-4A89-8B80-34C2B8203631Q34483568-6D005C2D-90C6-4124-AB88-5584F278DF3DQ35007339-ECE38005-E398-42D8-8BE5-C0B76B74E26FQ35122783-A8DA0E91-3943-4ED5-BD45-01C7E7BADC5BQ35123216-BFE4E5C5-1CA9-4C23-9418-424CB1380CC0Q35164695-69F61170-8340-4AEF-A277-6978D8C8588FQ35236345-F41005E8-3CB2-44AC-B0DE-72D406E99EDCQ35606725-6704C353-339A-4EAA-9FAB-06AFE023DBE0Q35650353-BFC2FEBF-6492-4F2F-A8EC-7AD312BC1FFCQ35731648-CBDBDBAA-14E3-40DB-9D8C-4540A8A9CFA0Q35779848-0409C276-7A9B-404B-96AE-A45471CC8320Q35855011-31DFBA27-8903-400A-8302-07A439ED70FAQ35911433-742B877A-9263-46BC-8A06-0A2D93F96F10Q35941437-0545F92D-0BCE-4143-984D-F6B74EA596C4Q35957271-771802CD-98C6-4BBE-BA1F-C85FCA12F1F1Q35965884-D45FB567-7CFA-4409-BCD8-8EABDF6B1FA5Q36109980-F7725842-EDB1-45DB-BB5E-C74AAA6AC8C5Q36123997-DA2C21D2-281E-492B-B9FE-C30629E4F598Q36201412-8BE919F8-E5CC-48D7-B46E-5135F4A0A531Q36294085-7951CF5B-947C-45EA-BE5B-CCE4C8145119Q36335361-A1FE8933-FBDB-43D3-AB9B-BB5C34043591Q36407266-F157CBE6-DE99-4281-A328-FCC6624AB9CBQ36432328-4158CFB4-2D84-4958-8EAF-99D713381A90Q36450108-D5569FAA-0BD9-4A6D-859C-8365603D5369Q36605014-DA7377AA-F3BC-4A46-BB3C-77D05790DFB3
P2860
Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Morphine causes rapid increase ...... ible HIV-1 Tat transgenic mice
@en
Morphine causes rapid increase ...... ble HIV-1 Tat transgenic mice.
@nl
type
label
Morphine causes rapid increase ...... ible HIV-1 Tat transgenic mice
@en
Morphine causes rapid increase ...... ble HIV-1 Tat transgenic mice.
@nl
prefLabel
Morphine causes rapid increase ...... ible HIV-1 Tat transgenic mice
@en
Morphine causes rapid increase ...... ble HIV-1 Tat transgenic mice.
@nl
P2093
P2860
P921
P356
P1433
P1476
Morphine causes rapid increase ...... ible HIV-1 Tat transgenic mice
@en
P2093
Annadora J Bruce-Keller
Ashok Chauhan
Avindra Nath
Eric J Smart
Jadwiga Turchan-Cholewo
Kurt F Hauser
Pamela E Knapp
Rollie Reid
Ruqiang Xu
Theresa Geurin
P2860
P304
P356
10.1002/GLIA.20708
P577
2008-10-01T00:00:00Z